Background To date, no immunological data on COVID-19 heterologous vaccination schedules
in humans have been reported. We assessed the immunogenicity and reactogenicity of …

Background: Since the confirmation of the first patient infected with SARS-CoV-2 in Spain in
January 2020, the epidemic has grown rapidly, with the greatest impact on the region of …

Background Despite the availability of effective vaccines against COVID-19, booster
vaccinations are needed to maintain vaccine-induced protection against variant strains and …

The pharmacological properties of melatonin are well known. However, there is noticeable
the lack of clinical trials that confirm the efficacy, security, absence of side effects in the short …

Background In the current epidemic of Ebola virus disease, health-care workers have been
transferred to Europe and the USA for optimised supportive care and experimental treatments…

Fast, high-throughput methods for measuring the level and duration of protective immune
responses to SARS-CoV-2 are needed to anticipate the risk of breakthrough infections. Here …

Background The clinical presentation of COVID-19 in patients admitted to hospital is
heterogeneous. We aimed to determine whether clinical phenotypes of patients with COVID-19 can …

Several cytochrome P450 (CYP) CYP3A polymorphisms were associated with reduced
enzyme function. We aimed to evaluate the influence of these alleles on the pharmacokinetic …

Background: The first generic PPI was introduced in Spain in 2001, and since then their
prescriptions have increased steadily by about 200%. Aim: To evaluate the frequency of use and …

Objective To develop and validate a prediction model of mortality in patients with COVID-19
attending hospital emergency rooms. Design Multivariable prognostic prediction model. …